267 related articles for article (PubMed ID: 25071447)
1. Chemokine receptor expression by inflammatory T cells in EAE.
Mony JT; Khorooshi R; Owens T
Front Cell Neurosci; 2014; 8():187. PubMed ID: 25071447
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
4. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
5. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
6. Expanded lung T-bet+RORγT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype.
Kaiser Y; Lepzien R; Kullberg S; Eklund A; Smed-Sörensen A; Grunewald J
Eur Respir J; 2016 Aug; 48(2):484-94. PubMed ID: 27230441
[TBL] [Abstract][Full Text] [Related]
7. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
8. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
9. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
10. CCL20/CCR6 chemokine signaling is not essential for pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Sachi N; Kamiyama N; Saechue B; Ozaka S; Dewayani A; Ariki S; Chalalai T; Soga Y; Fukuda C; Kagoshima Y; Ekronarongchai S; Kobayashi T
Biochem Biophys Res Commun; 2023 Jan; 641():123-131. PubMed ID: 36527746
[TBL] [Abstract][Full Text] [Related]
11. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver.
Oo YH; Banz V; Kavanagh D; Liaskou E; Withers DR; Humphreys E; Reynolds GM; Lee-Turner L; Kalia N; Hubscher SG; Klenerman P; Eksteen B; Adams DH
J Hepatol; 2012 Nov; 57(5):1044-51. PubMed ID: 22796894
[TBL] [Abstract][Full Text] [Related]
12. The heterogeneous human memory CCR6+ T helper-17 populations differ in T-bet and cytokine expression but all activate synovial fibroblasts in an IFNγ-independent manner.
Dankers W; den Braanker H; Paulissen SMJ; van Hamburg JP; Davelaar N; Colin EM; Lubberts E
Arthritis Res Ther; 2021 Jun; 23(1):157. PubMed ID: 34082814
[TBL] [Abstract][Full Text] [Related]
13. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
[TBL] [Abstract][Full Text] [Related]
14. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
15. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
van Langelaar J; van der Vuurst de Vries RM; Janssen M; Wierenga-Wolf AF; Spilt IM; Siepman TA; Dankers W; Verjans GMGM; de Vries HE; Lubberts E; Hintzen RQ; van Luijn MM
Brain; 2018 May; 141(5):1334-1349. PubMed ID: 29659729
[TBL] [Abstract][Full Text] [Related]
16. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.
Coursey TG; Gandhi NB; Volpe EA; Pflugfelder SC; de Paiva CS
PLoS One; 2013; 8(11):e78508. PubMed ID: 24223818
[TBL] [Abstract][Full Text] [Related]
18. CCR6
Restorick SM; Durant L; Kalra S; Hassan-Smith G; Rathbone E; Douglas MR; Curnow SJ
Brain Behav Immun; 2017 Aug; 64():71-79. PubMed ID: 28336414
[TBL] [Abstract][Full Text] [Related]
19. A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis.
Tsiogkas SG; Mavropoulos A; Dardiotis E; Zafiriou E; Bogdanos DP
Clin Exp Immunol; 2022 Oct; 210(1):79-89. PubMed ID: 35925616
[TBL] [Abstract][Full Text] [Related]
20. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
